ES2027897A6 - Procedimiento de preparacion de nuevos derivados de la difenilmetilpiperacina. - Google Patents

Procedimiento de preparacion de nuevos derivados de la difenilmetilpiperacina.

Info

Publication number
ES2027897A6
ES2027897A6 ES9100181A ES9100181A ES2027897A6 ES 2027897 A6 ES2027897 A6 ES 2027897A6 ES 9100181 A ES9100181 A ES 9100181A ES 9100181 A ES9100181 A ES 9100181A ES 2027897 A6 ES2027897 A6 ES 2027897A6
Authority
ES
Spain
Prior art keywords
group
substituted
diphenylmethylpiperazine
derivatives
diphenylmethylpiperazine derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES9100181A
Other languages
English (en)
Inventor
Venero Aurelio Orjales
Cires Luisa Slonso
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Faes Farma SA
Original Assignee
Fabrica Espanola de Productos Quimicos y Farmaceuticos FAES SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fabrica Espanola de Productos Quimicos y Farmaceuticos FAES SA filed Critical Fabrica Espanola de Productos Quimicos y Farmaceuticos FAES SA
Priority to ES9100181A priority Critical patent/ES2027897A6/es
Priority to PT97509A priority patent/PT97509A/pt
Priority to EP92500007A priority patent/EP0496691A1/en
Priority to JP4011407A priority patent/JPH0692932A/ja
Publication of ES2027897A6 publication Critical patent/ES2027897A6/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/28—Nitrogen atoms
    • C07D295/32—Nitrogen atoms acylated with carboxylic or carbonic acids, or their nitrogen or sulfur analogues

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyridine Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

PROCEDIMIENTO DE PREPARACION DE NUEVOS DERIVADOS DE LA DIFENILMETILPIPERACINA. SE DESCRIBE LA PREPARACION DE NUEVOS DERIVADOS DE LA DIFENILMETILPIRACINA, DE FORMULA: EN DONDE A ES UN GRUPO BENZHIDRILO, OPCIONALMENTE SUSTITUIDO POR UN ATOMO DE UN HALOGENO, PREFERENTEMENTE CLORO; B ES UN GRUPO CARBONILO, ACILAMINO, ACILAMINOALQUILO O METILO, Y C ES UN GRUPO ARILO, SUSTITUIDO O NO, HETEROARILO, SUSTITUIDO O NO, ARILALQUILO O HETEROARILALQUILO, ASI COMO SUS SALES DE ADICION CON ACIDOS FARMACEUTICAMENTE ACEPTABLES. ESTOS COMPUESTOS PRESENTAN ACTIVIDAD FARMACOLOGICA, EN PARTICULAR ANTIHISTAMINICA Y ANTIALERGICA.
ES9100181A 1991-01-24 1991-01-24 Procedimiento de preparacion de nuevos derivados de la difenilmetilpiperacina. Expired - Lifetime ES2027897A6 (es)

Priority Applications (4)

Application Number Priority Date Filing Date Title
ES9100181A ES2027897A6 (es) 1991-01-24 1991-01-24 Procedimiento de preparacion de nuevos derivados de la difenilmetilpiperacina.
PT97509A PT97509A (pt) 1991-01-24 1991-04-29 Novos derivados da difenilmetilpiperazina. processo para a sua preparacao
EP92500007A EP0496691A1 (en) 1991-01-24 1992-01-23 Diphenylmethylpiperazine derivatives
JP4011407A JPH0692932A (ja) 1991-01-24 1992-01-24 ジフェニルメチルピペラジン誘導体

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9100181A ES2027897A6 (es) 1991-01-24 1991-01-24 Procedimiento de preparacion de nuevos derivados de la difenilmetilpiperacina.

Publications (1)

Publication Number Publication Date
ES2027897A6 true ES2027897A6 (es) 1992-06-16

Family

ID=8270912

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9100181A Expired - Lifetime ES2027897A6 (es) 1991-01-24 1991-01-24 Procedimiento de preparacion de nuevos derivados de la difenilmetilpiperacina.

Country Status (4)

Country Link
EP (1) EP0496691A1 (es)
JP (1) JPH0692932A (es)
ES (1) ES2027897A6 (es)
PT (1) PT97509A (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998037077A1 (en) * 1997-02-24 1998-08-27 Zymogenetics, Inc. Calcitonin mimetics
US6943168B2 (en) 1998-06-30 2005-09-13 Neuromed Technologies Inc. Calcium channel inhibitors comprising benzhydril spaced from piperazine
US6951862B2 (en) 1998-06-30 2005-10-04 Neuromed Technologies, Inc. Calcium channel blockers comprising two benzhydril moieties
US7186726B2 (en) * 1998-06-30 2007-03-06 Neuromed Pharmaceuticals Ltd. Preferentially substituted calcium channel blockers
SE9902551D0 (sv) * 1999-07-02 1999-07-02 Astra Pharma Prod Novel compounds
SE9902987D0 (sv) 1999-08-24 1999-08-24 Astra Pharma Prod Novel compounds
CO5300399A1 (es) 2000-02-25 2003-07-31 Astrazeneca Ab Heterocicliocs que contienen nitrogeno, proceso para su preparacion y composiciones farmaceuticas que los contienen
US7005439B2 (en) 2000-06-20 2006-02-28 Astrazeneca Ab Compounds
AR028948A1 (es) 2000-06-20 2003-05-28 Astrazeneca Ab Compuestos novedosos
GB0104050D0 (en) 2001-02-19 2001-04-04 Astrazeneca Ab Chemical compounds
AR035230A1 (es) 2001-03-19 2004-05-05 Astrazeneca Ab Compuestos de bencimidazol, proceso para su preparacion, composicion farmaceutica, proceso para la preparacion de dicha composicion farmaceutica, y usos de estos compuestos para la elaboracion de medicamentos
GB0107228D0 (en) 2001-03-22 2001-05-16 Astrazeneca Ab Chemical compounds
SE0101038D0 (sv) 2001-03-23 2001-03-23 Astrazeneca Ab Novel compounds
SE0103818D0 (sv) 2001-11-15 2001-11-15 Astrazeneca Ab Chemical compounds
SE0301369D0 (sv) 2003-05-09 2003-05-09 Astrazeneca Ab Chemical compounds
TW200738634A (en) 2005-08-02 2007-10-16 Astrazeneca Ab New salt

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4993379A (es) * 1973-01-16 1974-09-05
JPS59118765A (ja) * 1982-12-24 1984-07-09 Fujisawa Pharmaceut Co Ltd ピペラジン誘導体
US4778796A (en) * 1985-07-19 1988-10-18 Dainippon Pharmaceutical Co., Ltd. ω-(3-pyridyl)alkenamide derivatives and anti-allergenic pharmaceutical compositions containing same
FR2655988B1 (fr) * 1989-12-20 1994-05-20 Adir Cie Nouveaux derives de la napht-1-yl piperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
JPH0692932A (ja) 1994-04-05
PT97509A (pt) 1992-07-31
EP0496691A1 (en) 1992-07-29

Similar Documents

Publication Publication Date Title
GR3020369T3 (en) Xanthine derivatives
AU2001293233A1 (en) Aza heterocyclic derivatives and their therapeutic use
KR960702464A (ko) Dc-89 유도체[dc-89 derivative]
ES2027898A6 (es) Procedimiento de preparacion de nuevos derivados de la 2-metoxifenilpiperacina.
AU667920B2 (en) New piperidine derivatives of benzimidazole
GR3021338T3 (en) Novel arylcycloalkyl derivatives their production and their use
AU4540789A (en) Imide derivatives, and their production and use
ES538418A0 (es) Un derivado de indol-3-carboxamida
EP0326307A3 (en) Novel pyridazinone derivatives and pharmaceutical preparations containing them
ES8503686A1 (es) Procedimiento de preparar derivados de penicilina.
DK240084D0 (da) New beta-carboline-3-oxadiazolyl derivatives
YU54189A (en) Process for obtaining cephem derivatives and midproducts for the same
EP0314098A3 (en) Imide derivatives, their production and use
CS274700B2 (en) Method of bu-3608 antibiotics' complex n-alkyl derivatives production
IE45901L (en) Pyridine derivatives
AU578489B2 (en) Proline derivatives
AU584270B2 (en) Novel derivatives of erythromycylamine
DK0571012T3 (da) Monokvaternære 2,16-bispiperidinylandrostanderivater
IT1212723B (it) Derivato dell'acido tiolattico ad attivita'broncosecretogoga.
ES464068A1 (es) Procedimiento para la obtencion de derivados de quinclona
ES8301933A1 (es) "procedimiento para la preparacion de derivados de 4-(5)-alcohil-mercaptoimidazoles".
IE40722L (en) Indolopiperidino -alkylphenothiazines
SU1573800A1 (ru) Производные о-аминобензойной кислоты, обладающие фунгицидными свойствами
MY102089A (en) Antibacterial compounds.
HU9202484D0 (en) Method for producing medical preparatives containing 1,4-dihydro-pyridine derivatives

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19991102